In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Gathungu is concerned that the Sh89.4 million lost annually could have been used to improve health infrastructure, increase ...

COVID-19 spring booster can cut your risk of hospitalization by over 40%! If you're 75+, immunocompromised, or in a care home, you’re eligible. Stay protected—book your jab now.

Measles vaccination rates for young children may be as low as 71% in younger children, well below the threshold needed for ...

The United States cutting funding to Gavi, an organisation that provides vaccines to the world’s poorest countries, could result in more than a million … Continue reading US Cutting Gavi Vaccine Allia ...

The new head of the Food and Drug Administration previously made headlines for his comments during the COVID-19 pandemic.

Despite official statistics, measles vaccination coverage among young children in the US may be significantly lower than ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 202 ...

The NHS has launched its 2025 Spring Booster COVID vaccine campaign, aiming to protect vulnerable populations. Find out if ...

Its overdependence on vaccines leaves the country vulnerable to bioterrorism.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.